These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11406841)

  • 21. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
    Tu D
    Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maximum likelihood estimation in survival studies under progressive interval censoring with random removals.
    Xiang L; Tse SK
    J Biopharm Stat; 2005; 15(6):981-91. PubMed ID: 16279356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing approaches for overdispersion in poisson regression versus the generalized poisson model.
    Yang Z; Hardin JW; Addy CL; Vuong QH
    Biom J; 2007 Aug; 49(4):565-84. PubMed ID: 17638291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A permutation test for inference in logistic regression with small- and moderate-sized data sets.
    Potter DM
    Stat Med; 2005 Mar; 24(5):693-708. PubMed ID: 15515134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Test homogeneity of risk difference across subgroups in clinical trials.
    Zhang L; Yang H; Cho I
    J Biopharm Stat; 2009; 19(1):67-76. PubMed ID: 19127467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heteroscedastic one-factor models and marginal maximum likelihood estimation.
    Hessen DJ; Dolan CV
    Br J Math Stat Psychol; 2009 Feb; 62(Pt 1):57-77. PubMed ID: 17935662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simulated percentage points for the null distribution of the likelihood ratio test for a mixture of two normals.
    Thode HC; Finch SJ; Mendell NR
    Biometrics; 1988 Dec; 44(4):1195-201. PubMed ID: 3233255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the pi* goodness of fit index for finite mixtures of item response models.
    Revuelta J
    Br J Math Stat Psychol; 2008 May; 61(Pt 1):93-113. PubMed ID: 18482477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing the ratio of two poisson rates.
    Gu K; Ng HK; Tang ML; Schucany WR
    Biom J; 2008 Apr; 50(2):283-98. PubMed ID: 18311854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Likelihood approaches to the non-parametric two-sample problem for right-censored data.
    Troendle JF; Yu KF
    Stat Med; 2006 Jul; 25(13):2284-98. PubMed ID: 16217854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling survival data with a cured fraction using frailty models.
    Price DL; Manatunga AK
    Stat Med; 2001 May 15-30; 20(9-10):1515-27. PubMed ID: 11343371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after allogeneic bone marrow transplantation for hematological malignancies with non-remission status. Results of a single-center study of 24 patients.
    Tabata M; Satake A; Okura N; Yamazaki Y; Toda A; Nishioka K; Tanaka H; Chin M; Itsukuma T; Yamaguchi M; Misawa M; Kai S; Hara H
    Ann Hematol; 2002 Oct; 81(10):582-7. PubMed ID: 12424540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The likelihood ratio for comparing means when a portion of the subjects fail to respond.
    Johnson WD; Kelly AM
    J Biopharm Stat; 1993 Mar; 3(1):73-84. PubMed ID: 8485537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of agreement under nonstandard conditions using regression models for mean and variance.
    Choudhary PK; Tony Ng HK
    Biometrics; 2006 Mar; 62(1):288-96. PubMed ID: 16542257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A likelihood approach to analyzing clinical trial data when treatments favor different outcomes.
    McClure LA; Brown MB
    Contemp Clin Trials; 2006 Aug; 27(4):340-52. PubMed ID: 16426899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of three different models for estimating relative risk in meta-analysis of clinical trials under unobserved heterogeneity.
    Kuhnert R; Böhning D
    Stat Med; 2007 May; 26(11):2277-96. PubMed ID: 16991109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test of treatment effect in pre-drug and post-drug count data with zero-inflation.
    Paul SR; Jiang X; Rai SN; Balasooriya U
    Stat Med; 2004 May; 23(10):1541-54. PubMed ID: 15122735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing differences between nested covariance structure models: Power analysis and null hypotheses.
    MacCallum RC; Browne MW; Cai L
    Psychol Methods; 2006 Mar; 11(1):19-35. PubMed ID: 16594765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.